AC Bioscience SA

SME

AC Bioscience SA

Description

AC BioScience Ltd is a pre-clinical stage biotechnology company dedicated to developing innovative therapies for the treatment of tumoral and immunological pathologies.
ACB2112, a molecule in the Azole group, enhances the efficacy of checkpoint-inhibitor immune-therapy. Outstanding results found in reducing tumor burden in the CT26 model for CRC

AC Bioscience SA

Address

Route de la Corniche 4, 1066 Epalinges, Switzerland

Contact

info@ac-bioscience.com

Description

AC BioScience Ltd is a pre-clinical stage biotechnology company dedicated to developing innovative therapies for the treatment of tumoral and immunological pathologies.
ACB2112, a molecule in the Azole group, enhances the efficacy of checkpoint-inhibitor immune-therapy. Outstanding results found in reducing tumor burden in the CT26 model for CRC

Matchmaking

Connect with AC Bioscience SA

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

TRL